Formosa Laboratories

Formosa Laboratories, Inc. is a significant producer of Active Pharmaceutical Ingredients (APIs) and UV-filters, operating from modern facilities near Taipei, Taiwan. The company's commitment to quality is underscored by its GMP compliance, which has received approvals from regulatory bodies including the US FDA, Germany's BGV, the EDQM, and Japan's PMDA. This extensive regulatory validation enables Formosa Laboratories to serve global markets effectively. Its primary API offerings encompass a wide range of Vitamin D derivatives such as Alfacalcidol, Calcitriol, Calcipotriol, Doxercalciferol, and Paricalcitol, alongside other critical compounds like Balsalazide, Benzonatate, Capsaicin, Colesevelam, Gadodiamide, Flupentixol, Melitracen, Meprobamate, Montelukast, Mycophenolate Mofetil, Sevelamer (HCl and Carbonate), and Taltirelin. The company is also a major global supplier of UV-filter products, notably avobenzone and Octinoxate, catering to the cosmetics and personal care industries.

With an operational footprint of 500 - 1,000 employees and a single primary location, Formosa Laboratories focuses on specialized chemical synthesis and production. The company provides comprehensive custom synthesis services, guiding projects from initial process development through to full commercial production, complete with robust documentation support. This capability positions Formosa Laboratories as a versatile partner for pharmaceutical and specialty chemical development. Meet Formosa Laboratories's team to understand the expertise driving these advanced manufacturing and development processes.

Formosa Laboratories leverages its technical expertise and stringent quality control to maintain a competitive edge in the global pharmaceutical and chemical sectors. Its product portfolio and custom synthesis capabilities cater to a B2B market, emphasizing reliability and adherence to international standards. The company's strategic focus on high-value APIs andView more...